Guidelines for the Treatment of Chronic Hepatitis B and C Viral Infections in Kenya
(2014; 62 pages)


Both acute and chronic hepatitis cause significant morbidity and mortality in sub-Saharan Africa. Over the years, it has only been possible to offer patients preventive and supportive care. Fortunately, during the last 10 years, effective therapies have emerged for chronic hepatitis especially HBV and HCV. The field is growing quite rapidly with new classes of drugs being brought into the market every six months or so.

Due to the rapid development, the situation has become confusing for most clinicians especially in determining when to start treatment, how to follow treated and untreated patients, when to stop treatment and the optimal therapies to use.

The Gastroenterology Society of Kenya, therefore, found it necessary to develop guidelines for practicing clinicians in Kenya, who treat HBV and HCV. These guidelines contain brief notes on the clinical picture and presentation, diagnosis and currently recommended treatment in our region for both HBV and HCV. The authors have taken into account the fact that Kenya has limited resources for healthcare.

These guidelines are not meant to be utilized as a textbook on hepatitis but as a quick reference tool for clinicians. Where further reading may be required, appropriate references have been suggested.

Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 1 décembre 2019